Who is sponsoring NCT02551146?

NCT02551146 is sponsored by Philipps University Marburg.

What drugs are being tested in NCT02551146?

Interventions in NCT02551146: A Locator with retention elements, B Locator without retention elements.

What condition does NCT02551146 study?

NCT02551146 studies Mouth, Edentulous.

Is NCT02551146 still recruiting?

NCT02551146 is currently terminated. Last updated 22 December 2022.

Last reviewed 2022-12-22 · How we verify

NCT02551146: GC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Influence of Implants and Locators for Improved Retention

Terminated NA Last updated 22 December 2022

What this trial tests

NA trial testing A Locator with retention elements in Mouth, Edentulous in 14 participants. Terminated before completion.

Timeline

7 September 2015

Primary endpoint
17 May 2018

17 May 2018

Quick facts

Lead sponsor	Philipps University Marburg
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	14
Start date	7 September 2015
Primary completion	17 May 2018
Estimated completion	17 May 2018
Sites	1 location across Germany

Drugs / interventions tested

A Locator with retention elements
B Locator without retention elements

Conditions studied

Mouth, Edentulous — all drugs for Mouth, Edentulous →

Sponsor

Philipps University Marburg

Who can join

Adults 45 to 80, any sex, with Mouth, Edentulous. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to assess the influence of this particular treatment method on the patients' quality of life and masticatory function.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Philipps University Marburg trials

Trials by the same sponsor.

NCT07498803 — Sota-ES - Sotatercept in Patients With Congenital Heart Disease and Eisenmenger´s Syndrome · Phase 2 · not yet recruiting
NCT07388004 — Group Therapy for Major Depression: Comparing Expectation-Focused and Reward-Focused Psychotherapy Approaches · NA · recruiting
NCT07166692 — Evaluation of a Retrieval Augmented Large Language Model as a Diagnostic Copilot in Rheumatology · NA · completed
NCT06865534 — Large Language Models to Aid Gynecological Oncology Treatment · NA · recruiting
NCT06968897 — Neurological Development In Toddlers After Maternal SARS-CoV-2 Infection During Pregnancy · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02551146 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Philipps University Marburg
Last refreshed: 22 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02551146.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing